Clinical outcome of corticosteroids in the treatment of COPD exacerbations in China

Trial Identifier:	D589BR00037
Sponsor:	AstraZeneca
NCTID::	NCT03633838
Start Date:	February 2017
Primary Completion Date:	February 2017
Study Completion Date:	February 2017
Condition:	Pulmonary Hypertension

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China, Shanghai	Shanghai, China, 201000

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.